HuagongsheHuagongshe Chemistry Print Report · For research reference only
6,7-Dihydro-[1,4]dioxino[2,3-c]pyridazine-3-carbaldehyde → 1-(2-{4-[(6,7-dihydro[1,4]dioxino[2,3-c]pyridazin-3-ylmethyl)amino]-1-piperidinyl}ethyl)-5,7-difluoro-2(1H)-quinolinone Diformate
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 6,7-Dihydro-[1,4]dioxino[2,3-c]pyridazine-3-carbaldehyde | HCID 24891696 | — |
| Reactant | 1-[2-(4-Amino-1-piperidinyl)ethyl]-5,7-difluoro-2(1H)-quinolinone | HCID 66774002 | — |
| Product | 1-(2-{4-[(6,7-dihydro[1,4]dioxino[2,3-c]pyridazin-3-ylmethyl)amino]-1-piperidinyl}ethyl)-5,7-difluoro-2(1H)-quinolinone Diformate | HCID 86635325 | — |
Reaction Steps
The title compound was prepared by the general method of Example 32(g) using 1-[2-(4-amino-1-piperidinyl)ethyl]-5,7-difluoro-2(1H)-quinolinone and 6,7-dihydro[1,4]dioxino[2,3-c]pyridazine-3-carbaldehyde to give the desired product directly as the diformate salt (34 mg; 15%).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08071592B2 |
| Source dataset | uspto-grants-2011_12 |
| ORD ID | ord-bc1cea900d8c49bda267665fa72d0ce7 |
| Source note | uspto-grants-2011_12 |